# CBD and Genetics: Why Everyone Responds Differently

By Robin Roy Krigslund-Hansen | 12+ years in CBD industry
Last updated: January 21, 2026

---

## Quick Summary

Genetic variations explain much of why people respond differently to CBD. Key genes affect CBD metabolism (CYP enzymes), cannabinoid receptor density (CNR1, CNR2), endocannabinoid breakdown (FAAH), and other targets. Understanding pharmacogenomics may eventually allow personalized CBD recommendations, though current testing has limitations.

---

## The Genetic Basis of Response

Individual CBD response varies due to:

1. **Metabolic genes** - How quickly you break down CBD
2. **Receptor genes** - How many cannabinoid receptors you have
3. **Enzyme genes** - How your endocannabinoid system functions
4. **Target genes** - How other CBD targets respond

---

## Metabolism Genes (CYP450 Family)

### CYP2C19

**Most important for CBD metabolism**

| Variant | Frequency | Effect |
|---------|-----------|--------|
| *1/*1 (Normal) | ~60% | Standard metabolism |
| *2, *3 (Poor) | ~3-5% (varies by ethnicity) | Slow metabolism, higher CBD levels |
| *17 (Ultrarapid) | ~5-30% | Fast metabolism, lower CBD levels |

**Implications:**
- Poor metabolizers may need lower doses
- Ultrarapid metabolizers may need higher doses
- Drug interactions more significant in poor metabolizers

### CYP3A4

**Secondary CBD metabolizer**

- Also metabolizes ~50% of all medications
- Genetic variants affect activity
- Less characterized than CYP2C19 for CBD

---

## Cannabinoid Receptor Genes

### CNR1 (CB1 Receptor)

Variations affect:
- Receptor density in brain
- Response to cannabinoids
- Baseline anxiety levels
- Pain sensitivity

**Notable variants:**
- rs1049353: Associated with anxiety, obesity
- rs806379: Linked to substance use risk
- Multiple SNPs affect expression levels

### CNR2 (CB2 Receptor)

Variations affect:
- Immune function
- Inflammatory response
- Bone density
- Pain perception

**Notable variants:**
- Q63R: Common functional variant
- Affects immune cell CB2 density
- May influence inflammatory conditions

---

## Endocannabinoid Enzyme Genes

### FAAH (Fatty Acid Amide Hydrolase)

FAAH breaks down anandamide. Less FAAH activity = more anandamide.

**Key variant: rs324420 (C385A)**
- AA genotype: ~38% less FAAH activity
- Higher natural anandamide levels
- Reduced anxiety trait
- May need less CBD supplementation
- ~20% of population carries A allele

**Implications:**
- People with low FAAH activity have naturally higher endocannabinoid tone
- May already have good ECS function without CBD
- Or may respond differently to CBD (system already active)

### MGLL (Monoglyceride Lipase)

Breaks down 2-AG:
- Variations less studied
- Affects 2-AG levels
- Influences CB2 system particularly

---

## Other Relevant Genes

### TRPV1 (Vanilloid Receptor)

CBD activates TRPV1 for pain effects:
- Variants affect pain sensitivity
- May influence CBD's pain-relieving effects
- Capsaicin sensitivity correlates

### HTR1A (Serotonin 5-HT1A Receptor)

CBD's anxiolytic effects involve 5-HT1A:
- Variants affect receptor density
- Influence antidepressant/anxiolytic responses
- May affect CBD's anxiety benefits

### COMT (Catechol-O-Methyltransferase)

Affects dopamine/stress response:
- Val158Met variant well-studied
- Influences stress resilience
- May affect CBD response to anxiety

---

## Ethnicity and CBD Response

CYP enzyme frequencies vary by population:

| CYP2C19 Variant | European | Asian | African |
|-----------------|----------|-------|---------|
| Poor metabolizer | 2-5% | 15-25% | 2-5% |
| Ultrarapid | 20-30% | 1-3% | 10-20% |

**Implications:**
- Dosing recommendations may need population adjustment
- Current research primarily in Western populations
- More diverse studies needed

---

## Pharmacogenomic Testing

### Available Tests
- Consumer genetic tests (23andMe, etc.) include some relevant SNPs
- Clinical pharmacogenomic panels test CYP variants
- Not specific to CBD but informative

### What Testing Can Tell You
- Metabolizer status (fast/normal/slow)
- Potential drug interactions
- Some risk factors

### Limitations
- CBD-specific testing not validated
- Many relevant genes not fully understood
- Gene-gene interactions complex
- Environment matters too

---

## Beyond Genetics: Epigenetics

Genes aren't destiny:

### Factors That Modify Gene Expression
- Stress and trauma history
- Diet and nutrition
- Exercise patterns
- Sleep quality
- Environmental exposures

### Endocannabinoid System Plasticity
- ECS can be upregulated or downregulated
- Lifestyle affects receptor expression
- Not fixed by genetics alone

---

## Practical Implications

### Current Recommendations
Since genetic testing for CBD is not standardized:

1. **Start low, go slow** - Accounts for metabolizer variation
2. **Track response** - You are your own experiment
3. **Consider family history** - Some traits cluster in families
4. **Note other drug responses** - May indicate metabolizer status

### Future Potential
- Personalized CBD recommendations based on genotype
- Dose calculators incorporating genetic factors
- Better prediction of responders vs non-responders

---

## My Take

Genetics helps explain the frustrating reality that the same CBD dose affects people completely differently. The person who feels profound effects from 10mg may have slow CYP2C19 metabolism and naturally low FAAH activity, while someone who needs 100mg to feel anything may be an ultrarapid metabolizer with robust baseline endocannabinoid tone.

We're not yet at the point where genetic testing can reliably guide CBD dosingâ€”but we're moving in that direction. For now, understanding that genetic variation exists helps set realistic expectations: if CBD doesn't work for you at typical doses, you're not necessarily doing something wrong; you may just be genetically different from the "average" responder.

---

## Related Topics

- [CBD Pharmacokinetics](/knowledge/cbd-pharmacokinetics)
- [CBD Metabolism Pathways](/knowledge/cbd-metabolism-pathways)
- [CBD Dose-Response](/knowledge/cbd-dose-response)
- [Why CBD Affects People Differently](/knowledge/individual-cbd-response)

---

*This article is for educational purposes only.*
